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Ionophore-based potentiometric PVC membrane sensors for 
determination of phenobarbitone in pharmaceutical formulations
The fabrication and development of two polyvinyl chloride 
(PVC) membrane sensors for assaying phenobarbitone so-
dium are described. Sensors 1 and 2 were fabricated utiliz-
ing b- or g-cyclodextrin as ionophore in the presence of tri-
dodecylmethylammonium chloride as a membrane additive, 
and PVC and dioctyl phthalate as plasticizer. The analytical 
parameters of both sensors were evaluated according to the 
IUPAC guidelines. The proposed sensors showed rapid, 
stable anionic response (–59.1 and –62.0 mV per decade) over 
a relatively wide phenobarbitone concentration range 
(5.0 × 10–6–1 × 10–2 and 8 × 10–6–1 × 10–2 mol L–1) in the pH range 
of 9–11. The limit of detection was 3.5 × 10–6 and 7.0 × 10–6 mol L–1 
for sensors 1 and 2, respectively. The fabricated sensors 
show ed high selectivity for phenobarbitone over the investi-
gated foreign species. An average recovery of 2.54 µg mL–1 
phenobarbitone sodium was 97.4 and 101.1 %, while the 
mean relative standard deviation was 3.0 and 2.1 %, for sen-
sors 1 and 2, respectively. The results acquired for determi-
nation of phenobarbitone in its dosage forms utilizing the 
proposed sensors are in good agreement with those ob-
tained by the British Pharmacopoeial method.
Keywords: phenobarbitone sodium, membrane selective elec-
trode, b-cyclodextrin, g-cyclodextrin, PVC, potentiometry
 
Phenobarbitone is mostly utilized as an anticonvulsant with minimum requirements 
of medical care (1). Its chemical structure is 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione. 
Developed countries use phenobarbitone medication for the treatment of epilepsy (2) as 
recommended by the World Health Organization. It is also used in the treatment of sei-
zures in children (3). Phenobarbitone is also used to treat sleeping disorders, anxiety and 
drug withdrawal (1). 
Spectrophotometry (4), chemiluminescence (5), conductometry (6), voltammetry (7), 
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(10, 11), GC-MS (12, 13) and capillary electrophoresis (14) have been cited in the literature 
as analytical techniques for phenobarbitone determination. On the other hand, the vast 
majority of these techniques include tedious, sophisticated instruments, complicated pro-
cedures and require highly qualified personnel. Potentiometric sensors based on PVC 
membrane are simple, rapid, sensitive and economical and are applied as analytical tools 
in different areas (15–17).
Only one potentiometric sensor for phenobarbitone has been cited (18). The cited 
method was based on the use of phenobarbitone-tetraoctylammonium ion-pair in the PVC 
membrane sensor (18). The calibration range was 1 × 10–1 to 2 × 10–4 mol L–1. 
Cyclodextrins are widely used in different areas, especially in preparation of chemical 
sensors (19), due to their complexation properties (20, 21). Cyclodextrin has a cage-like 
supramolecular structure that enables inclusion complex formation between the host cav-
ity (seven and eight membered ring cavity, respectively, for β- and g-CD) and the guest. 
The main driving forces for inclusion complexes include van der Waals interactions, hy-
drophobic interactions, hydrogen bonding between the polar groups of guest molecules 
and the CDs hydroxyl groups and electrostatic interactions for ionic guests (20, 21). 
The present study describes two new potentiometric membrane sensors for the assay 
of phenobarbitone in pharmaceuitical formulations based on the use of β- (sensor 1) and 
g-cyclodextrin (sensor 2) as sensing matrial in the PVC matrix.
EXPERIMENTAL 
Apparatus
A pH/mV meter (model 523) (WTW, Germany), utilizing a phenobarbitone membrane 
sensor in conjunction with an Orion double junction Ag/AgCl reference electrode (model 
90-02) (Thermo, USA) containing 10 % (m/V) potassium nitrate in the external compart-
ment, was utilized for potentiometric measurements. All pH measurements were done 
using a combined Ross glass pH electrode (Thermo). All potentiometric assays were car-
ried out at 25 ± 1 °C.
Reagents and materials
High molecular mass polyvinyl chloride powder (PVC), dibutyl sebacate (DBS), dioc-
tyl phthalate (DOP), o-nitrophenyl octylether (NPOE) and tetrahydrofuran (THF) (purity 
> 99 %) were obtained from Aldrich Chemical Company (Germany). Phenobarbitone so-
dium was obtained from Sigma Chemical Company (Germany). Tridodecylmethylam-
Fig. 1. Chemical structure of phenobarbitone sodium, C12H11N2NaO3, Mr 254.22.
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monium chloride (TDMACl) and cyclodextrins (b-CD and g-CD) were obtained from Al-
drich (Switzerland). Phenobarbital sodium injection 200 mg mL–1 was from BDH (UK). All 
chemicals and reagents were of analytical reagent grade and doubly distilled water was 
used.
Preparation of standard solutions
The stock solution of phenobarbitone sodium (1 ́  10–2 mol L–1) was prepared by dissolv-
ing an appropriate amount of phenobarbitone in water. Working solutions were prepared by 
suitable dilution with water. The concentration range was from 1 1́0–2 to 1 1́0–6 mol L–1.
Fabrication of phenobarbitone PVC membrane sensors 
In a glass Petri dish (5 cm in diameter), 0.35 mL of DBS or DOP or NPOE, 5 mg of 
TDMACl and 190 mg of PVC powder was added, mixed well, and then 10 mg of b- or g-CD 
was added. After mixing, 5.0 mL THF was added. After the solvent was allowed to evap-
orate overnight, the sensing PVC membrane was shaped. The PVC membrane was cut 
with a stopper borer (10 mm inner size) and stuck to a polyethylene tube (3 cm length, 8 
mm i.d.) using THF. The electrode body used comprised a glass tube, to whose end the 
polyethylene tube was attached. A PVC membrane disk of 1 cm was attached to the poly-
ethylene tube. The inner solution of the working electrode contained equal volumes of 
1 ´ 10–2 mol L–1 phenobarbitone and 1 ´ 10–2 mol L–1 KCl (22, 23). An inner reference elec-
trode of Ag/AgCl type was used. The indicator electrode was soaked in phenobarbitone 
solution when not in use.
Sensor calibration 
The phenobarbitone PVC sensors were calibrated by inserting them, together with 
the reference electrode, in a 50-mL measuring cell containing 9.0 mL of 1 ´ 10–2 mol L–1 
sodium sulphate. One-mL aliquot of phenobarbitone solution was added and equilibrat-
ed under continuous stirring, to give the final phenobarbitone concentration from 1 ́  10–2 
to 1 ´ 10–6 mol L–1. The potential was recorded after adjustment to ± 1 mV and the calibra-
tion curve was obtained by plotting the recorded potential against the negative logarithm 
of phenobarbitone concentration. It was utilized for the determination of unknown phe-
nobarbitone.
Determination of phenobarbitone 
Five mL of Phenobarbital sodium® injection, 200 mg mL–1, were transferred into a 50-mL 
measuring flask and completed to the mark with water and then further diluted 10 times 
with 1 ´ 10–2 mol L–1 sodium sulphate. The expected final concentration was 2 mg mL–1. The 
potential of the resulting solution was recorded using developed sensors and the concentra-
tion was calculated from the calibration curve. 
Synthetic laboratory powder was prepared by addition of a known amount of phe-
nobarbitone powder (10 mg) to the mixture of excipients (magnesium stearate, glucose, 
lactose monohydrate, starch, microcrystalline cellulose (240 mg). The whole powder 
mass (250 mg) was completely dissolved in water (~50 mL) with sonication for about 10 
min. The solution was filtered, transferred completely to a 100-mL measuring flask and 
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completed with water to the mark with distilled water. Ten mL of the solution was trans-
ferred into a 100-mL measuring flask, 10 mL of 1 ´ 10–2 mol L–1 sodium sulphate was 
added and completed with water to the mark. The final concentration was 10 mg mL–1. 
The concentration of phenobarbitone in the synthetic mixture was assayed using the 
proposed methods. 
Validation of new sensors
The relation between the average potential and the measured concentration of new 
sensors is logarithmic, according to the Nernstian equation:
 E = E0 – S log [concentration] 
where E is the electrode potential, E0 is the standard electrode potential, and S is the slope. 
Validation was performed as indicated by the IUPAC guidelines (24). Lower limit of detec-
tion (LOD) and lower limit of quantification (LOQ) were calculated according to IUPAC 
(24), LOD was the cross-point of two extrapolated fitted lines (the medium and the lowest 
one of E vs. log concentration curve) of the calibration function, whereas limit of quantifica-
tion (LOQ) was 3.3 ´ LOD.
Accuracy and precision. – Accuracy of the phenobarbitone assay was ascertained by 
addition of a known amount of phenobaritone into a pure solution. Percent accuracy was 
calculated as the closeness of the found to added concentrations. 
On the other hand, precision was expressed as RSD in %. The precision of the devel-
oped methods was examined by carrying out the analysis during the day and over three 
different days. The five replicate results were used for both accuracy and precision during 
intra- and inter-day testing.
The analysis of phenobarbitone by two different operators and two different instru-
ments on diverse days was carried out to evaluate the intermediate precision of the pro-
posed sensors. 
RESULTS AND DISCUSSION
Optimization of PVC membrane sensor composition 
Phenobarbitone is one of the molecules that form an inclusion complex with cyclodex-
trin (25, 26). The ability to form a complex is a function of space of the phenobarbitone 
guest molecule and its suitability to fit with the cavity of cyclodextrin host (Fig. 2).
Ionic additive. – The role of TDMACl as an ionic additive, being composed of the 
large cationic moiety and small anion, to the sensing materials (β-CD or g-CD) in the 
PVC membrane sensor is to reduce ionic interference and to lower electrical resistance 
of the membrane (27, 28). Therefore both selectivity and sensitivity of the membrane 
were enhanced.
Membrane plasticizer. – b- and g-CD ionophores, combined with different plasticizers, 
namely, DOP, DBS and o-NPOE to give different combinations, were studied. It is well 
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known that the construction of PVC-based membrane sensors requires the use of a plasti-
cizer, which acts as a fluidizer allowing homogeneous dissolution and diffusion mobility 
of the ions inside the membrane (29).
The investigated sensors using either b- or g-cyclodextrin with two plasticizers (DOP 
or o-NPOE) were found appropriate. The best results were obtained with DOP. Hence, 
DOP was used as plasticizer when developing the proposed sensors.
Performances and operating conditions
The response time and operative lifetime were evaluated according to the IUPAC 
guidelines (24). The time required for the electrode potential to reach a constant reading 
± 1.0 mV is defined as the response time. The response time was found to be 25 s at ≥ 1 ´ 10–3 
mol L–1 phenobarbitone and 30 s at ≤ 1 ´ 10–4 mol L–1 phenobarbitone.
Potential of the proposed sensors was recorded daily in the same solution and it was 
found stable for about ± 1.0 mV for about one month. During this period, the potential slope 
was constant (–59.0 ± 0.5 and –62.0 ± 0.5 mV per decade, for sensors 1 and 2, resp.). After 
that time (more than five weeks), the efficiency of the membrane decreased. Then the mem-
brane sensor should have been replaced by a new section from the master membrane op-
erating with high precision.
Effect of pH. – The two created sensors were studied in the pH range 2–11. Fig. 3. shows 
the potential-pH profile of the phenobarbitone sensors. The potential-concentration profile 
demonstrated that the slopes of the proposed sensors were constant (–59.1 ± 1.0 and –62.0 ± 
1.0 mV per decade) for sensor 1 and sensor 2, respectively, and the potential was found stable 
in the pH range 9–11 (Figs. 4). At pH lower than 7.4, there was an increase in potential due to 
the formation of phenylbarbituric acid (pKa = 7.4) (30), while phenobarbitone anion existed in 
the pH range 9–11. Therefore this pH range was found to be most suitable for both sensors.
Validation of the method
Analytical performances of the sensors are shown in Tables I and II. Linear response 
was observed over the concentration range of 5 × 10−6 to 1 × 10−2  and 8 × 10−6 to 1 × 10−2 mol L–1 
phenobarbitone for sensors 1 and 2, resp., in the pH range of 9.0 to 11.0. 
Fig. 2. Chemical structure of: a) β-cyclodextrine, b) g-cyclodextrine, c) toroidal shape.
a)                                                           b)                                                                 c)
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The calibration line was defined as follows:
 E (mV) = –S log [phenobarbitone] + intercept 
where E is electrode potential, S is the slope of the calibration graph (–59.1 ± 0.5 and
–62.0 ± 0.5 mV per decade ) and intercept (–15.1 ± 0.5 and –51.6 ± 0.5 mV) for sensors 1 and 2, 
resp. (Fig. 4).
According to the IUPAC suggestion (24), the limit of detection (LOD) and limit of 
quantification (LOQ) of the suggested procedures were found to be 1.5 × 0–6 and 2.4 × 10–6
mol L–1 and 5.0 × 10–6and 8.0 × 10–6 mol L–1 phenobarbitone for sensors 1 and 2, respectively 
(Table I). β-cyclodextrin sensor showed a lower detection limit compared to g-CD but both 
Fig. 3. pH profile of phenobarbitone sensors: a) sensor 1 with β-CD and b) sensor 2 with g-CD, using: 
1 × 10–3 (empty triangles) and 1 × 10–4 (empty circles) mol L–1 phenobarbitone.
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sensors showed a 100-fold lower detection limit compared to 2 × 10–4 mol L–1 published by 
Lima et al. (18). 
 The influence of interferences was checked by measuring the potentiometric selectiv-
ity coefficients using the separate solutions method according to the IUPAC guidelines (24, 
31). The selectivity coefficient potA,BK  was estimated from the following equation:
 –log potA,BK  = E1-E2/S
Table I. Analytical performances of phenobarbitone-PVC sensors
Parameter Sensor 1 Sensor 2
Phenobarbitione calibration range (mol L–1) 3.6 ´ 10 –6 – 1 ´ 10–2 –62.0 ± 0.5
Working pH range 9 – 11 –51.6 ± 0.5
Calibration line slope (mV per decade) –59.1 ± 0.5 –62.0 ± 0.5
Calibration line intercept (mV) –15.1 ± 0.5 –51.6 ± 0.5
STEYX 1.83 5.295
SE slope 0.8 2.0
SE intercept 3.0 9.0
Coefficient of determination (R2) 0.999 0.996
LOQ (mol L–1) 5.0 ´ 10–6 8.0 ´ 10–6
LOD (mol L–1) 1.5 ´ 10–6 2.4 ´ 10–6
Response time (1 ´ 10–3 mol L–1 phenobarbitone) (s) 25.0 ± 0.5 25.0 ± 0.5
SE slope – standard error of the slope, SE intercept – standard error of the intercept
STEYX – standard error for the line of best fit, through a supplied set of y- (E, mV) and x- (log concentration) values. 
Standard error of the predicted y-value for each x in the regression.
LOD, LOQ – limit of detection, quantification.
Fig. 4. Calibration curve of phenobarbitone membrane sensors (in 10–2 mol L–1 sodium sulphate). Cali-
bration curve equations for β- (sensor 1) and g-CD (sensor 2) are: y = –59.1x–15.1 and y = –62.0x–51.6, 
respectively. 
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where E1 is the potential measured in the phenobarbitone solution, E2 is the potential mea-
sured in the solution of the interfering species and S is the slope of the developed sensor. 
The assay was performed for several species such as benzoate, caffeine, lactose, starch, 
magnesium stearate, microcrystalline cellulose, etc. The results are presented in Table II. 
They show that the selectivity coefficient values were low (1.6 × 10–3 – 9 × 10–3), indicating 
selectivity of the proposed sensors. 
Accuracy and precision were examined at 2.54 mg mL–1 (1 × 10–5 mol L–1) of phenobar-
bitone sodium during a day and on three different days. The within-day recovery was 97.4 
and 101.1 %, while the inter-day recovery was 97.0 and 100.0 % for sensors 1 and 2, respec-








Na+ 3.0 ´ 10–3 2.4 ´ 10–3
K+ 3.0 ´ 10–3 2.3 ´ 10–3
Fe2+ 3.1 ´ 10–3 2.5 ´ 10–3
Ca2+ 3.1 ´ 10–3 2.3 ´ 10–3
Acetate 1.6 ´ 10–3 2.6 ´ 10–3
Phosphate 3.2 ´ 10–3 6.8 ´ 10–3
Citrate 3.2 ´ 10–3 2.5 ´ 10–3
Benzoate 3.18 ´ 10–3 2.6 ´ 10–3
Caffeine 3.2 ´ 10–3 3.0 ´ 10–3
Magnesium stearate 4.46 ´ 10–3 9.1 ´ 10–3
Glucose 4.43 ´ 10–3 9.2 ´ 10–3
Lactose monohydrate 4.41 ´ 10–3 9.1 ´ 10–3
Starch 4.42 ´ 10–3 9.2 ´ 10–3
Microcrystalline cellulose 4.45 ´ 10–3 9.1 ´ 10–3
PB – phenobarbitone
Table III. Determination of phenobarbitone using the proposed PVC membrane sensors
Phenobarbitone added 
(mg mL–1)
 Model recovery (% ± RSD)a
 Sensor 1 Sensor 2 
2.54 102.7 ± 3.9 101.1 ± 3.3 
25.42 98.2 ± 2.5 102.0 ± 2.0 
254.21 98.2 ± 2.0 97.4 ± 1.5 
2542.1 98.0 ± 1.8 98.0 ± 1.4 
a n= 6
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tively. On the other hand, intra-day precision RSD for five replicates was 3.0 and 2.1 % for 
sensors 1 and 2, respectively, while the inter-day imprecision was 3.2 and 2.5 % for sensors 
1 and 2, respectively.
Analyses of phenobarbitone done by two different operators on two diverse instru-
ments on three different days gave RSD lower than 3.5 % as a measure of intermediate 
precision. Preliminary investigation of the proposed method under different conditions 
indicated that the suggested procedures are fairly robust and the only factor that must be 
controlled is the pH of the measuring medium, which should be in the range of 9 to 11. 
Application of phenobarbitone sensors
The analyses of model phenobarbitone solutions (2.0 – 2542.1 mg mL–1) with the sug-
gested sensors indicate high model precision and accuracy of both sensors. The obtained 
results are displayed in Table III. The recovery ranged 98.0–102.7 and 98.0–101.1 % for sen-
sors 1 and 2, respectively. RSD was in the range of 1.8–3.9 and 1.4–3.3 % for sensors 1 and 
2, respectively.
Recovery of a known amount of phenobarbitone in synthetic laboratory powder was 
also checked with the proposed sensors. Recovery values of 98.3 and 98.8 % with RSD of 
1.9 and 3.0 % for sensors 1 and 2, respectively were found. This was compared with the 
British pharmacopoeia (32) method, which showed an avarge recovery of 98.0 % with th RSD 
value of 2.3 %. On the other hand, determination of phenobarbitone in the injection solu-
tion exhibited recovery of 99.0 and 98.6 % with RSD of 2.0 and 3.2 %, compared to the refer-
ence method with an avarge recovery of 98.5 % and RSD of 1.5 %. The obtained results are 
presented in Table IV. 
The data listed in Table IV shows good agreement with the reference method (32), 
with experimental F values for both sensors and both formulations lower than the tabu-
lated value (33). Comparison between the experimental means for the two methods for p 
= 0.05 and n = 6 was carried out. It was found that t for both sensors and for both formula-
tions was lower than the theoretical value (33). This data has proven that the results ob-
tained by both semsors are of comparable precision and accuracy to that of the reference 
method.







Proposed method British Pharmaco-
poeia (ref. 32)
F-test t-test







2Found RSD (%) Found RSD (%) Found RSD (%)
Synthetica 10 mg 9.93 mg 1.9 9.88 mg 3.0 9.8 mg 2.3 1.46 1.74 0.41 0.52






mg mL–1 1.5 1.67 4.31 0.5 0.07
a Laboratory prepared synthetic tablet.
b Phenobarbital sodium injection 200 mg mL–1 (BDH, UK).
Tabulated values of F and t are 4.3874 and 2.8 for p = 0.05 and n = 6, respectively.
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CONCLUSIONS
Two PVC membrane sensors for the assay of phenobarbitone were constructed and 
optimized. The developed sensors used β- or g- cyclodextrin as a neutral ionophore, dioc-
tyl phthalate as a plasticizer and tridodecylmethylammonium chloride as a cationic ex-
cluser. Both sensors show good accuracy and precision in the pH range 9-11 and are of 
comparable performances. Our sensors show a wider linear range and a lower limit of 
detection compared to those reported in the literature (18). Sensor 1 shows higher sensitiv-
ity and wider dynamic range compared to sensor 2.
The suggested sensors offer the advantages of high sensitivity and fast response and 
could be used for the determination of phenobarbitone in its formulations.
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